ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25 | -37.5% | 7,986 | 0.0% | 0.00% | – |
| Q2 2023 | $40 | -2.4% | 7,986 | -3.2% | 0.00% | – |
| Q1 2023 | $41 | -35.9% | 8,246 | -19.1% | 0.00% | -100.0% |
| Q4 2022 | $64 | -99.9% | 10,192 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $110,000 | -4.3% | 10,192 | +1.0% | 0.00% | 0.0% |
| Q2 2022 | $115,000 | +35.3% | 10,093 | +7.9% | 0.00% | 0.0% |
| Q1 2022 | $85,000 | -71.7% | 9,350 | -53.6% | 0.00% | 0.0% |
| Q4 2021 | $300,000 | +14.5% | 20,172 | +98.1% | 0.00% | -50.0% |
| Q3 2021 | $262,000 | -7.7% | 10,184 | -6.4% | 0.00% | 0.0% |
| Q2 2021 | $284,000 | +4.8% | 10,875 | +41.7% | 0.00% | -80.0% |
| Q1 2021 | $271,000 | +27.2% | 7,676 | -8.9% | 0.01% | +25.0% |
| Q4 2020 | $213,000 | -32.6% | 8,426 | +0.5% | 0.01% | -42.9% |
| Q3 2020 | $316,000 | -4.8% | 8,380 | +8.0% | 0.01% | -6.7% |
| Q2 2020 | $332,000 | – | 7,762 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $45,386,000 | 9.32% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $472,400,000 | 5.23% |
| Wildcat Capital Management, LLC | 1,515,524 | $38,252,000 | 4.81% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 900,143 | $22,720,000 | 3.28% |
| Coastal Bridge Advisors, LLC | 385,824 | $9,738,000 | 1.93% |
| Casdin Capital, LLC | 945,000 | $23,852,000 | 0.71% |
| DSAM Partners (London) Ltd | 208,798 | $5,270,000 | 0.62% |
| BAINCO INTERNATIONAL INVESTORS | 152,839 | $3,858,000 | 0.44% |
| Pier Capital, LLC | 152,071 | $3,838,000 | 0.41% |
| Woodline Partners LP | 567,539 | $14,325,000 | 0.38% |